COVID-19 - Important considerations for developing and using a vaccine.

Hum Vaccin Immunother

Department of Plant Production, College of Food and Agriculture Science, King Saud University, Riyadh, Saudi Arabia.

Published: February 2021

The novel coronavirus SARS-CoV-2 after emerging in China has caused a global pandemic that is risking the lives of millions. COVID-19 has spread across the world at a very rapid rate raising concerns of capacity limitations and lack of unified responses at the global level, particularly from the world's most developed countries. The spread of further infection has been curtailed by lockdown and mass social distancing that has been enforced in most parts of the world. There are no clinical data yet suggesting that any available candidate vaccine will be effective for COVID-19 which will be a critical need for eventually preventing this disease. Extensive research is underway with some success in identification of monoclonal antibodies from COVID-19 recovered patients, which may inform on vaccine development. The clinical evaluations of COVID-19 vaccines need to follow standardized protocols that are essential for safeguarding humans. In absence of a vaccine or a widely available effective therapy, quarantine and other preventive measures are essential in curtailing the risk of pandemic spread.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899667PMC
http://dx.doi.org/10.1080/21645515.2020.1781507DOI Listing

Publication Analysis

Top Keywords

covid-19
5
covid-19 considerations
4
considerations developing
4
vaccine
4
developing vaccine
4
vaccine novel
4
novel coronavirus
4
coronavirus sars-cov-2
4
sars-cov-2 emerging
4
emerging china
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!